Bionano Genomics to Present at the 42nd Annual Cowen Healthcare Conference
03. März 2022 16:38 ET
|
Bionano Genomics
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClincial™, a leading software...
Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
01. März 2022 16:05 ET
|
Bionano Genomics
Full-year 2021 revenue growth of 111% over 2020Achieved publicly announced anticipated milestones for 2021Strong balance sheet with $250.6 million in cash, cash equivalents, and available-for-sale...
Bionano Genomics Announces Launch of Its Rare Undiagnosed Genetic Disease (RUGD) Strategic Initiative Aimed at the 350 Million People Globally Living with a Rare Disease
28. Februar 2022 08:00 ET
|
Bionano Genomics
Rare diseases affect more than 350 million people globallyIt is estimated that 1 in 15 people globally are affected by a rare diseaseEstimates are that 25 million Americans and 30 million in Europe...
Bionano Genomics to Report Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call and Webcast on March 1st, 2022
22. Februar 2022 16:30 ET
|
Bionano Genomics
SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 1st, 2022 at 4:30 p.m....
Bionano Genomics Announces Publication of Prospective Study Demonstrating Performance Improvements from OGM in the Analysis of AML and MDS Compared to Traditional Methods
22. Februar 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software...
Bionano Genomics Appoints Helene Klein as its First Ever Chief People Officer
14. Februar 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software...
Bionano Genomics Announces First Publication Demonstrating OGM as an Alternative to Karyotyping for Product of Conception Sample Analysis
11. Februar 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software...
Bionano Genomics to Present at the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
09. Februar 2022 16:30 ET
|
Bionano Genomics
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software...
Bionano Genomics Announces UK Footprint Expansion with Adoption of its Saphyr® System for Optical Genome Mapping in Two Genetic Laboratory Hubs within the United Kingdom’s National Health Service
02. Februar 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software...
Bionano Genomics Announces Publication of the First Study to Combine OGM and NGS to Evaluate Myeloid Cancers
26. Januar 2022 08:00 ET
|
Bionano Genomics
Whole genome analysis by OGM together with analysis using a 523-gene NGS panel can perform better and cost less than analysis with karyotyping, FISH, and a 54-gene NGS panelFirst study to publish...